Home
David Stamler - CEO - Alterity Therapeutics (ASX:ATH) is a clinical-stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.
Alterity Therapeutics (ASX:ATH) - Webinar Presentation
PUBLISHED
2024-02-02
Content
David Stamler - CEO - Alterity Therapeutics (ASX:ATH) is a clinical-stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.
Author
| Name | Finance News Network |